Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiopharma Cred. Regulatory News (BPCR)

Share Price Information for Biopharma Cred. (BPCR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.878
Bid: 0.878
Ask: 0.88
Change: -0.002 (-0.23%)
Spread: 0.002 (0.228%)
Open: 0.882
High: 0.882
Low: 0.878
Prev. Close: 0.88
BPCR Live PriceLast checked at -
BioPharma Credit is an Investment Trust

To generate long-term shareholder returns, predominantly in the form of sustainable income distributions from exposure to the life sciences industry.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

20 Oct 2017 17:00

RNS Number : 2511U
BioPharma Credit PLC
20 October 2017
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

BioPharma Credit PLC

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Details of person subject to the notification obligation

Name

Prudential plc group of companies

City and country of registered office (if applicable)

London, United Kingdom

4. Full name of shareholder(s) (if different from 3.)

Name

Prudential plc

The Prudential Assurance Company Limited

M&G Group Limited

M&G Limited

M&G Investment Management Limited

City and country of registered office (if applicable)

London, United Kingdom

5. Date on which the threshold was crossed or reached:

19/10/2017

6. Date on which issuer notified (DD/MM/YYYY):

20/10/2017

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuer

Resulting situation on the date on which threshold was crossed or reached

14.88%

0.00%

14.88%

761,877,360

Position of previous notification (if

applicable)

14.30%

0.00%

14.30%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

 

A: Voting rights attached to shares

 

Class/type ofshares

ISIN code (if possible)

Number of voting rights

% of voting rights

 

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

 

ORD USD0.01

GB00BDGKMY29

113,382,100

14.88%

 

 

 

SUBTOTAL 8. A

113,382,100

14.88%

 

 

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

 

Type of financial instrument

Expirationdate

Exercise/Conversion Period

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

 

 

 

 

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

 

Type of financial instrument

Expirationdate

Exercise/Conversion Period

Physical or cash

settlement

Number of voting rights

% of voting rights

 

 

 

 

SUBTOTAL 8.B.2

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

 

 

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer

 

 

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary)

X

 

 

Name

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

 

 

Prudential plc

(Parent Company)

 

14.88%

0.00%

14.88%

 

 

The Prudential Assurance Company Limited (wholly owned subsidiary of

Prudential plc)

14.29%

0.00%

14.29%

 

 

M&G Group Limited

(wholly owned subsidiary of Prudential plc)

14.88%

0.00%

14.88%

 

 

M&G Investment

Management Limited

(wholly owned subsidiary of M&G Limited)

14.88%

0.00%

14.88%

 

 

M&G Limited

(wholly owned subsidiary of M&G Group Limited)

14.88%

0.00%

14.88%

 

 

10. In case of proxy voting, please identify:

 

 

Name of the proxy holder

N/A

 

 

The number and % of voting rights held

N/A

 

 

The date until which the voting rights will be held

N/A

 

 

11. Additional information

 

 

 

 

 

Place of completion

London, United Kingdom

Date of completion

20 October 2017

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLURUVRBWARUAA
Date   Source Headline
3rd May 20246:15 pmRNSTransaction in Own Shares
2nd May 20246:15 pmRNSTransaction in Own Shares
2nd May 202412:18 pmRNSNEW INVESTMENT OF UP TO US$400 MILLION
1st May 202410:25 amRNSTotal Voting Rights
30th Apr 20246:15 pmRNSTransaction in Own Shares
29th Apr 20246:15 pmRNSTransaction in Own Shares
26th Apr 20246:15 pmRNSTransaction in Own Shares
24th Apr 20246:15 pmRNSTransaction in Own Shares
24th Apr 20247:00 amRNSNEW INVESTMENT OF UP TO US$100 MILLION
23rd Apr 20246:15 pmRNSTransaction in Own Shares
22nd Apr 20246:15 pmRNSTransaction in Own Shares
22nd Apr 20244:00 pmRNSNet Asset Value(s) and Monthly Factsheet
19th Apr 20246:15 pmRNSTransaction in Own Shares
18th Apr 20246:15 pmRNSTransaction in Own Shares
18th Apr 20246:00 pmRNSNotice of AGM
17th Apr 20246:15 pmRNSTransaction in Own Shares
16th Apr 20246:15 pmRNSTransaction in Own Shares
15th Apr 20246:15 pmRNSTransaction in Own Shares
12th Apr 20246:15 pmRNSTransaction in Own Shares
11th Apr 20246:15 pmRNSTransaction in Own Shares
10th Apr 20246:15 pmRNSTransaction in Own Shares
9th Apr 20246:15 pmRNSTransaction in Own Shares
8th Apr 20246:15 pmRNSTransaction in Own Shares
4th Apr 20246:15 pmRNSTransaction in Own Shares
3rd Apr 20246:15 pmRNSTransaction in Own Shares
2nd Apr 20246:15 pmRNSTransaction in Own Shares
27th Mar 20244:48 pmRNSDirector/PDMR Shareholding
27th Mar 20247:01 amRNSUPDATES TO THE DISCOUNT CONTROL MECHANISM
27th Mar 20247:00 amRNSFINAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2023
25th Mar 202411:35 amRNSDirector/PDMR Shareholding
21st Mar 20244:05 pmRNSDividend Declaration
21st Mar 20244:00 pmRNSNet Asset Value(s)
15th Mar 20244:35 pmRNSUPDATE ON INVESTMENT
11th Mar 20244:00 pmRNSNet Asset Value(s) and Monthly Factsheet
1st Mar 20243:10 pmRNSTotal Voting Rights
27th Feb 20247:00 amRNSNotice of Full Year Results
26th Feb 20246:15 pmRNSTransaction in Own Shares
20th Feb 20246:15 pmRNSTransaction in Own Shares
19th Feb 20246:15 pmRNSTransaction in Own Shares
16th Feb 20246:15 pmRNSTransaction in Own Shares
13th Feb 20246:15 pmRNSTransaction in Own Shares
13th Feb 20247:00 amRNSSTATEMENT RE IMMUNOGEN, INC.
9th Feb 20246:15 pmRNSTransaction in Own Shares
8th Feb 20246:15 pmRNSTransaction in Own Shares
8th Feb 20247:00 amRNSDividend Declaration
7th Feb 20246:15 pmRNSTransaction in Own Shares
6th Feb 20246:15 pmRNSTransaction in Own Shares
6th Feb 20247:00 amRNSSTATEMENT RE COHERUS BIOSCIENCES, INC.
1st Feb 202410:39 amRNSTotal Voting Rights
31st Jan 20244:00 pmRNSNet Asset Value(s) and Monthly Factsheet

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.